NEW DELHI/HYDERABAD: The nation’s drug regulator has authorised vaccine-maker Biological E’s Corbevax for emergency use among children in the 12-17 age group, making a third shot available in the coronavirus…
MUMBAI: A total of 11 billion Covid-19 vaccine doses were produced and delivered to countries globally in 2021, which is twice the volume of the total global vaccine market in…
Some healthcare specialists, who are entitled to get precautionary vaccine doses from January 10, have expressed concern over the government’s decision to use the same vaccine as the third dose.…
PUNE: Top experts in the country have backed the Centre’s stance on completion of nine months after the second shot of Covid vaccine for availing a precaution dose. A study…
The Central Drugs Standard Control Organisation (CDSCO) has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking to 12 the number of preventives and…
NEW DELHI: The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca Covid-19 vaccine Covishield declines after 3 months, has been misquoted, said experts. Speaking to…
A booster dose against COVID-19 increases the amount of circulating antibodies and is shown to increase protection from symptomatic infection with Omicron, scientists have said, underlining that boosters can be…
NEW DELHI: Interacting with ambassadors of Latin American and Caribbean nations, Union Health Minister Mansukh Mandaviya on Thursday said India is willing to supply Covishield and Covaxin to these countries.…
National Technical Advisory Group on Immunisation (NTAGI), the government’s advisory body on Covid-19 immunisation, is likely to take a decision on whether immunocompromised people should get an additional third dose…
Gurgaon: Shiv Kumar (50), a resident of Sector 30, felt relief in July after a nervous year and a half of manoeuvring through the pandemic when he got his second…
